Blood Samples Sample Clauses

Blood Samples. Blood samples will be taken by single needle-sticks or by a tube that is left in your arm. You cannot choose how the blood is taken. There will be 6 blood draws for participants in Cohort 1; there will be about 30 blood draws for participants in Cohorts 2-6. The total amount of blood drawn will be about 90 ml (about 50 ml for first cohort) or a little over 1/3 cup. For comparison, the standard blood donation is about 480 mL (two cups). Part 2 (Cohorts 7, 8, 9, and 10):
AutoNDA by SimpleDocs
Blood Samples. Blood samples for screening will be taken from your left or right arm using a needle and a collection vial. The total amount of blood xxxx at screening will be about 4 teaspoons (20 mL). Two teaspoons (10 mL) of blood will be collected each time a PK sample is taken at Visits 1, 2 and 3. The blood will be taken from a flexible tube called a catheter in your left or right arm. If the catheter cannot be used, blood may be drawn by needle stick. You cannot choose how the blood is taken. There will be 14 blood draws in a single dosing visit for the PK samples. The total amount of blood drawn for PK samples over the study will be about 2 cups (440 mL). For comparison, the standard blood donation is about 2 cups (480 mL). Because a catheter is being used to collect the PK blood samples, a small amount of blood will be drawn and discarded to clear the line before each PK blood draw. The amount drawn to be discarded is approximately 84 mL (about 1/3 cup).
Blood Samples. Blood samples will be obtained within one week from the catheterization procedure. Blood will be centrifugated to extract plasma and sera aliquots (for analysis of biomarkers) which will be stored in a refrigerator (-80°). Plasma and sera will be shipped to P1-CNR for analysis and final storage.
Blood Samples. Blood samples will be taken by single needle-sticks or by a tube that is left in your arm. You cannot choose how the blood is taken. There will be about 49 blood draws. The total amount of blood drawn will be about 146 mL or just over 1/2 cup. For comparison, the standard blood donation is about 480 mL (two cups).
Blood Samples. For both studies, blood was collected, handled, and stored in a manner to allow measurements of pro-/anti-oxidants, FIP, FOP, and CRP. The samples were drawn into red-coated, pre-chilled Vacutainer tubes, plunged into ice and shielded from light and immediately delivered to the laboratory where the blood was centrifuged in a refrigerated centrifuge. Plasma and serum were separated; aliquotted into O-ring-capped amber- colored cryopreservation vials; the air in the vials was displaced with inert gas (nitrogen in MAP I and argon in MAP II); and then immediately frozen at -70o C until analysis. Plasma lycopene, α-carotene, β-carotene, lutein, β-cryptoxanthin, and α-tocopherol levels from both studies were measured using high-performance liquid chromatography (HPLC) [150, 151]. The plasma free FIP were measured by a gas chromatography-mass spectrometry (GCMS) method [152] by the Molecular Epidemiology and Biomarker Research Laboratory (MEBRL) at the University of Minnesota (Minneapolis, MN). This method, considered the gold standard for the measurement of FIP, measures a well- defined set of F2-isoprostane isomers. The FIP were extracted from the participant’s sample using deuterium (4)-labeled 8-iso-prostaglandin F2 alpha as an internal standard. Unlabeled, purified F2-isoprostane was used as a calibration standard.
Blood Samples. 3.01.06.01 Effective July 1, 1993, Blood samples will be drawn and stored, to provide baseline blood testing for all represented personnel on a voluntary basis. These samples will not be tested at the time of the draw. The purpose of the blood draw is to provide a reference point for the future.

Related to Blood Samples

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Blood Donors The Employer agrees to allow the necessary time off with no loss of pay to employees who are called upon to donate blood to the Canadian Blood Services.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Samples The Contractor shall submit the following samples of Materials and relevant information to the Authority’s Engineer for pre-construction review:

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!